Johnson & Johnson’s sponsored AIDS film didn’t win at the Brand Film Festival in New York last week, but it had already won a different prize just a few days earlier.
Industry delegates say the US Food and Drug Administration (FDA) is showing increased support for continuous manufacturing, a stance C-SOPS told us is quality control-driven.
Just after opening a refurbished manufacturing facility in Cape Town, South Africa earlier this year, pharma giant Johnson & Johnson ($JNJ) recently opened the doors to its Global Public Health Africa Operations office there.nnThe company has invested $21 million (300 million rand) in the facilities. The global public health facility will focus on HIV, tuberculosis and maternal, newborn and child health, South Africa - The Good News reported.
Industry will be encouraged to adopt continuous manufacturing methods following the regulatory success of Janssen’s Prezista, says Rutgers University associate director and Interphex speaker Doug Hausner.
Janssen is already working on continuous manufacturing methods for other drugs says Rutgers University which helped develop the new Prezista production process approved by the US FDA.
New York-based Royalty Pharma has moved to tap into sales of Xtandi (enzalutamide) by paying a bit more than $1 billion in cash up front to buy a portion of future royalties of the prostate cancer drug from rights now held by the University of California, Los Angeles, and related parties